StonvexLoading…
StonvexStonvexStonvexCore line items from RYTM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $189.76M | $130.13M | $77.43M | $23.64M |
Operating Income | $-192.02M | $-265.50M | $-184.36M | $-179.16M |
Net Income | $-196.54M | $-260.60M | $-184.68M | $-181.12M |
EPS (Diluted) | $-3.11 | $-4.34 | $-3.20 | $-3.47 |
Total Assets | $480.20M | $392.27M | $332.75M | $382.48M |
Total Liabilities | $210.17M | $227.72M | $162.99M | $118.22M |
Cash & Equivalents | $54.30M | $89.14M | $60.08M | $127.68M |
Free Cash Flow OCF − CapEx | $-116.63M | $-113.88M | $-136.20M | $-173.71M |
Shares Outstanding | 67.21M | 62.39M | 59.43M | 56.61M |